ajpheart.00782.2002.—Statins have a variety of cardiopro-tective properties following chronic treatment. In contrast, little is known about the acute effects. Reperfusion acutely injures the heart by activation of neutrophils as well as endothelial cells. Because statins are known to influence the processes pathogenetically involved, we hypothesized that acute application of statins attenuates the sequelae of car-diac reperfusion. In rats, myocardial infarction (MI) was induced by ligature of the left coronary artery followed by reperfusion. Myocardial blood flow (MBF) was determined by H2 clearance and regional myocardial function (fractional thickening, FT) by pulsed Doppler. MI size was measured by triphenyltetrazolium chloride (TTC) sta...
International audienceBACKGROUND: Reperfusion of the ischemic myocardium is associated with increase...
Therapeutic strategies that modulate ventricular remodeling can be useful after acute myocardial inf...
We investigated the impact of cardioprotective drugs on ST-elevation, arrhythmias and infarct size i...
Statins, the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, are most frequ...
Background: In last decades there were many experimental interventions protecting myocardium against...
Background There has been controversy about whether early reperfusion of myocardial infarcts causes ...
The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been shown to upregula...
Objective The present study was designed to evaluate whether CP was beneficial in alleviating myocar...
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, referred to as “statins” have ...
Dyslipidemia is related to the progression of atherosclerosis and is an important risk factor for ac...
Impairment of left ventricular function is a major consequence of acute myocardial infarction. Sever...
Background: Myocardial ischemia–reperfusion represents a clinically relevant problem associated with...
Therapeutic strategies that modulate ventricular remodeling can be useful after acute myocardial inf...
Abstract3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, referred to as “statin...
Objective: Due to reported modulatory effects of statins on nitric oxide synthase (NOS) expression, ...
International audienceBACKGROUND: Reperfusion of the ischemic myocardium is associated with increase...
Therapeutic strategies that modulate ventricular remodeling can be useful after acute myocardial inf...
We investigated the impact of cardioprotective drugs on ST-elevation, arrhythmias and infarct size i...
Statins, the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, are most frequ...
Background: In last decades there were many experimental interventions protecting myocardium against...
Background There has been controversy about whether early reperfusion of myocardial infarcts causes ...
The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been shown to upregula...
Objective The present study was designed to evaluate whether CP was beneficial in alleviating myocar...
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, referred to as “statins” have ...
Dyslipidemia is related to the progression of atherosclerosis and is an important risk factor for ac...
Impairment of left ventricular function is a major consequence of acute myocardial infarction. Sever...
Background: Myocardial ischemia–reperfusion represents a clinically relevant problem associated with...
Therapeutic strategies that modulate ventricular remodeling can be useful after acute myocardial inf...
Abstract3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, referred to as “statin...
Objective: Due to reported modulatory effects of statins on nitric oxide synthase (NOS) expression, ...
International audienceBACKGROUND: Reperfusion of the ischemic myocardium is associated with increase...
Therapeutic strategies that modulate ventricular remodeling can be useful after acute myocardial inf...
We investigated the impact of cardioprotective drugs on ST-elevation, arrhythmias and infarct size i...